HK182096A - Novel calcium supplements - Google Patents

Novel calcium supplements Download PDF

Info

Publication number
HK182096A
HK182096A HK182096A HK182096A HK182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A
Authority
HK
Hong Kong
Prior art keywords
calcium
malate
calcium citrate
citrate malate
bone
Prior art date
Application number
HK182096A
Other languages
German (de)
English (en)
Inventor
Allen Jacobs Stephen
Original Assignee
Norwich Eaton Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals, Inc. filed Critical Norwich Eaton Pharmaceuticals, Inc.
Publication of HK182096A publication Critical patent/HK182096A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (5)

  1. Citrate-malate de calcium, ayant un rapport molaire calcium/citrate/malate de 6:2:3.
  2. Complexe de calcium contenant des ligands citrate et malate, selon la revendication 1.
  3. Supplément calcique comprenant une quantité sans danger et efficace d'un citrate-malate de calcium selon la revendication 1 et un véhicule pharmaceutiquement acceptable.
  4. Supplément calcique selon la revendication 3, sous une forme galénique unitaire comprenant de 425 mg à 2100 mg dudit citrate-malate de calcium.
  5. Supplément calcique selon la revendication 3, sous une forme galénique unitaire, dans lequel ledit véhicule pharmaceutiquement acceptable est présent en une proportion de 0,1% à 75% en poids.
HK182096A 1987-08-28 1996-10-03 Novel calcium supplements HK182096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
HK182096A true HK182096A (en) 1996-10-11

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
HK182096A HK182096A (en) 1987-08-28 1996-10-03 Novel calcium supplements

Country Status (13)

Country Link
EP (1) EP0304987B1 (fr)
JP (1) JP2795651B2 (fr)
KR (1) KR970009583B1 (fr)
AT (1) ATE82120T1 (fr)
AU (1) AU625809B2 (fr)
CA (1) CA1314233C (fr)
DE (1) DE3875867T2 (fr)
DK (1) DK481388A (fr)
HK (1) HK182096A (fr)
IE (1) IE61452B1 (fr)
IL (1) IL87452A (fr)
NZ (1) NZ225950A (fr)
ZA (1) ZA886355B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121719T1 (de) * 1990-06-14 1995-05-15 Procter & Gamble Calciumcitrat/malat-gemisch.
CA2102210C (fr) * 1991-05-06 1998-08-04 Mark Benson Andon Supplements combines de calcium et de vitamine d
WO1993012672A1 (fr) * 1991-12-26 1993-07-08 The Procter & Gamble Company Concentres pour boissons enrichis en calcium et stables en stockage
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
ATE140125T1 (de) * 1992-10-21 1996-07-15 Procter & Gamble Lagerfähige, kalziumzusatzenthaltende getränkekonzentrate und sirup
EP0665719B1 (fr) * 1992-10-21 1997-01-15 The Procter & Gamble Company Edulcorant contenant une source de calcium biodisponible concentre
WO1994008472A1 (fr) * 1992-10-21 1994-04-28 The Procter & Gamble Company Source de calcium biodisponible concentre
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品／冷蔵品およびその製造法
CN101505730B (zh) * 2006-08-17 2013-02-13 宝洁公司 包含柠檬酸苹果酸钙的组合物以及它们的制备方法
CN101505731B (zh) * 2006-08-17 2011-11-16 宝洁公司 包含柠檬酸苹果酸钙的组合物以及它们的制备方法
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
EP2790710B1 (fr) * 2011-12-13 2020-08-26 Amorphical Ltd. Carbonate de calcium amorphe pour le traitement de la malabsorption de calcium et de troubles métaboliques des os
HK1253702A1 (zh) 2015-06-04 2019-06-28 艾玛菲克有限公司 用聚磷酸/聚磷酸酯/聚磷酸盐或双膦酸/双膦酸酯/双膦酸盐稳定的无定形碳酸钙
JP7152785B2 (ja) 2016-10-25 2022-10-13 アモーフィカル リミテッド． 白血病治療のための非晶質炭酸カルシウム
IL289237B2 (en) 2019-07-23 2026-03-01 Amorphical Ltd Amorphous calcium carbonate for improving athletic performance
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
CA1319612C (fr) * 1987-07-02 1993-06-29 Haile Mehansho Supplements mineraux fer-calcium a biodisponibilite amelioree

Also Published As

Publication number Publication date
KR970009583B1 (en) 1997-06-14
IE61452B1 (en) 1994-11-02
JPH01156985A (ja) 1989-06-20
DK481388A (da) 1989-03-02
IE882610L (en) 1989-02-28
DE3875867D1 (de) 1992-12-17
JP2795651B2 (ja) 1998-09-10
EP0304987B1 (fr) 1992-11-11
AU2159888A (en) 1989-06-15
CA1314233C (fr) 1993-03-09
EP0304987A2 (fr) 1989-03-01
NZ225950A (en) 1991-10-25
AU625809B2 (en) 1992-07-16
DK481388D0 (da) 1988-08-29
IL87452A0 (en) 1989-01-31
IL87452A (en) 1992-07-15
EP0304987A3 (en) 1990-02-21
ATE82120T1 (de) 1992-11-15
KR890003391A (ko) 1989-04-14
ZA886355B (en) 1989-05-30
DE3875867T2 (de) 1993-04-01

Similar Documents

Publication Publication Date Title
EP0304987B1 (fr) Suppléments de calcium
US5128374A (en) Use of calcium citrate malate for the treatment of osteoporosis and related disorders
JP3708115B2 (ja) 混合カルシウム及びビタミンｄ補給品
US5314919A (en) Calcium supplements
EP0542912B1 (fr) Complements de calcium et de traces de mineraux
AU666654B2 (en) Calcium, trace mineral, vitamin D and drug therapy combinations
US5232709A (en) Calcium and trace mineral supplements comprising estrogen
HK1006149B (en) Calcium and trace mineral supplements
EP0304986B1 (fr) Utilisation de certains Calcium-Citrate-Malate pour l'obtention d'un médicament destiné au traitement de l'ostéoporose
WO2010008976A2 (fr) Compléments combinés de calcium, magnésium et vitamine d
CA2376017C (fr) Compositions de citrate de potassium et de calcium et methodes de production
KR20100107468A (ko) 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
US5905093A (en) Fish scale extract as a calcium supplement
HU211084B (en) Process for producing oral pharmaceutical composition of bone strengthening activity
JPH0840975A (ja) カルシウム−アルカリ金属クエン酸塩化合物、その製法及びこれを含有する医薬品
CA2159355C (fr) Methode et composition pour le traitement de l'osteoporose
WO1999040941A1 (fr) Extrait d'ecailles de poissons utilise comme supplement calcique
JPH09157174A (ja) カルシウム製剤

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080814